Hvis trombocyttallet stiger med mere end 150 x 109/ l, eller hvis trombocyttallet stiger til over øvre referencegrænse, skal behandlingen med NeoRecormon afbrydes.
If there is an increase in platelets of more than 150 x 109/ l or if platelets rise above the normal range, treatment with NeoRecormon should be discontinued.